IRONWOOD PHARMACEUTICALS, INC. Inventory
IRONWOOD PHARMACEUTICALS, INC. (IRWD) had Inventory of $648.00 thousand as of 2019-12-31, per its 10-K filed 2021-02-17.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:InventoryNet · last filed 2021-02-17
- 2019-12-31: Inventory, Net $648.00K.
- 2019-09-30: Inventory, Net $2.30M.
- 2019-06-30: Inventory, Net $1.74M.
- 2019-03-31: Inventory, Net $593.00K.
| Period end | Inventory, Net | Inventory, Net as first filed |
|---|---|---|
| 2019-12-31 | $648.00K 10-K · filed 2021-02-17 | |
| 2019-09-30 | $2.30M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $1.74M 10-Q · filed 2019-07-30 | |
| 2019-03-31 | $593.00K 10-Q · filed 2019-05-02 | |
| 2018-09-30 | $76.00K 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $1.10M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $1.71M 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $735.00K 10-K · filed 2019-02-25 | |
| 2017-09-30 | $479.00K 10-Q · filed 2017-11-02 | |
| 2017-03-31 | $1.51M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $1.08M 10-K · filed 2018-02-22 | |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $0.00 10-K · filed 2018-02-22 | |
| 2015-03-31 | $4.95M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $5.00M 10-K · filed 2017-02-22 | $4.95M 10-K · filed 2015-02-18 |
| 2014-09-30 | $13.04M 10-Q · filed 2014-11-05 | |
| 2014-06-30 | $12.99M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $23.41M 10-Q · filed 2014-04-29 | |
| 2013-12-31 | $22.14M 10-K · filed 2015-02-18 | |
| 2013-09-30 | $20.56M 10-Q · filed 2013-10-28 | |
| 2013-06-30 | $20.38M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $19.70M 10-Q · filed 2013-04-23 | |
| 2012-12-31 | $6.70M 10-K · filed 2014-02-07 | |
| 2012-09-30 | $965.00K 10-Q · filed 2012-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |